Disease-modifying treatment in progressive multiple sclerosis
JR Ciotti, AH Cross - Current treatment options in neurology, 2018 - Springer
Purpose of review Multiple sclerosis (MS) is an immune-mediated disorder that affects the
central nervous system (CNS), often first affecting people in early adulthood. Although most …
central nervous system (CNS), often first affecting people in early adulthood. Although most …
Disease-Modifying Treatment in Progressive Multiple Sclerosis
JR Ciotti, AH Cross - Current treatment options in …, 2018 - pubmed.ncbi.nlm.nih.gov
Purpose of review Multiple sclerosis (MS) is an immune-mediated disorder that affects the
central nervous system (CNS), often first affecting people in early adulthood. Although most …
central nervous system (CNS), often first affecting people in early adulthood. Although most …
[引用][C] Disease-Modifying Treatment in Progressive Multiple Sclerosis
JR Ciotti, AH Cross - Current Treatment Options in Neurology, 2018 - cir.nii.ac.jp
Disease-Modifying Treatment in Progressive Multiple Sclerosis | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …
Disease-Modifying Treatment in Progressive Multiple Sclerosis.
JR Ciotti, AH Cross - Current Treatment Options in Neurology, 2018 - europepmc.org
Multiple sclerosis (MS) is an immune-mediated disorder that affects the central nervous
system (CNS), often first affecting people in early adulthood. Although most MS patients …
system (CNS), often first affecting people in early adulthood. Although most MS patients …
Disease-Modifying Treatment in Progressive Multiple Sclerosis
JR Ciotti, AH Cross - Current Treatment Options in Neurology, 2018 - profiles.wustl.edu
Purpose of review: Multiple sclerosis (MS) is an immune-mediated disorder that affects the
central nervous system (CNS), often first affecting people in early adulthood. Although most …
central nervous system (CNS), often first affecting people in early adulthood. Although most …